Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q99581 (
FEV
)
3,296
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective:
The aim of this work was to compare matrix metalloproteinase-9 and -12, tissue inhibitor of metalloproteinase-1 and -4, and neutrophil elastase in exhaled breath condensate (EBC) and peripheral blood of patients with COPD.
Methods:
Peripheral blood and EBC samples from COPD patients and healthy donors were collected. In serum and EBC, MMP-9, MMP-12, NE, TIMP-1, and
TIMP-4
proteins were detected by ELISA. The mRNA expression levels of MMP-9, MMP-12, NE, TIMP-1, and
TIMP-4
in peripheral blood mononuclear cells (PBMCs) were analyzed by qRT-PCR.
Results:
The protein levels of MMP-9 (
p
=.034) and MMP-12 (
p
=.041) in the EBC of COPD smokers were higher than those of COPD never-smokers. The concentrations of TIMP-1 (
p
=.072) and
TIMP-4
(
p
=.084) in the EBC of COPD smokers were higher than those of COPD never-smokers; however, the difference was not statistically significant. MMP-9 (
r
=-0.78,
p
<.0001) and TIMP-1 (
r
=-0.71,
p
<.0001) levels in EBC were significantly negatively correlated with pulmonary function
FEV
1
%pred. The protein levels of MMP-12 (
r
=-0.37,
p
=.034) and
TIMP-4
(
r
=-0.34,
p
=.041) were also negatively correlated with FEV1%pred. The expression of MMP-9, MMP-12, NE, TIMP-1, and
TIMP-4
in PBMCs and serum of COPD smokers were significantly higher than those of control never-smokers (
p
<.05).
Conclusions:
Exhaled MMP-9, MMP-12, TIMP-1, and
TIMP-4
levels increased in stable COPD patients and were negatively correlated with FEV1%pred, which suggests the usefulness of their measurement in EBC for the monitoring of airway inflammation. However, to better assess their diagnostic or prognostic value, larger studies are necessary.
...
PMID:Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients. 3104 12